Main menu

Building capacity for public health bioinformatics in East Africa using a portable sequencing platform


George’s work aims to build capacity in viral outbreak surveillance and real-time portable nanopore sequencing, based on regional priorities.

George’s ‘Nanopore journey’ has developed over 4 or 5 yrs, with current focuses on metagenomic assays, amplicon sequencing of measles and rubella, and SARS-CoV-2.

They sequenced SARS-CoV-2 first in April 2020, shortly after the 1st Kenyan case was identified. ‘Now we have about 120 genomes that we have sequenced’.

Phylogenetic monitoring of SARS-CoV-2 in Kenya: from initial importation via international travel, now to local transmission.

Authors: George Githinji

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Nanopore technology

Subscribe to Nanopore updates Resources and publications What is the Nanopore Community

About Oxford Nanopore

News Company timeline Sustainability Leadership team Media resources & contacts For investors For partners Working at Oxford Nanopore Current vacancies Commercial information BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
English flag